Oak Family Advisors, LLC Vista Gen Therapeutics, Inc. Transaction History

Oak Family Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	BUY	$0.88 - $1.73 $166,333 - $326,995	189,015 Added 93.7%	390,742 $344,000
Q1 2022 May 03, 2022	BUY	$1.14 - $2.09 $19,619 - $35,968	17,210 Added 9.33%	201,727 $250,000
Q4 2021 Feb 02, 2022	BUY	$1.67 - $2.76 $13,850 - $22,891	8,294 Added 4.71%	184,517 $360,000
Q3 2021 Nov 10, 2021	BUY	$2.62 - $3.45 $17,485 - $23,025	6,674 Added 3.94%	176,223 $483,000
Q2 2021 Jul 29, 2021	BUY	$1.96 - $3.15 $195,212 - $313,733	99,598 Added 142.38%	169,549 $534,000

Q1 2021 May 05, 2021	SELL	$1.89 - $2.96 $26,365 - $41,292	-13,950 Reduced 16.63%	69,951 $0
Q4 2020 Feb 12, 2021	BUY	$0.65 - $1.94 $54,535 - $162,767	83,901 New	83,901 $0

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $730M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Oak Family Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Oak Family Advisors, LLC with notifications on news.